Adaptive Phase News Today

Vertex Pharmaceuticals Incorporated today announced that inaxaplin (VX-147) has advanced into the Phase 3 portion of the global Phase 2/3 pivotal clinical trial in APOL1-mediated kidney disease (AMKD), where a 45 mg once daily oral dose will be...

Operator: Good afternoon. And welcome to the MannKind Corporation 2023 First Quarter Financial Results Earnings Call.

DGAP-News: Imcyse SA / Key word(s): Study 13.04.2022 / 13:00 The issuer is solely responsible for the content of this announcement.   Imcyse Announces First Patient Dosed in Adaptive Phase 1/2 Clinical Trial of ImotopeTM IMCY-0141 for Multiple Sclerosis   IMCY-MS-001 study aims to determine safe...

Dear Editor, It is becoming increasingly clear that the NWMO lacks a social conscience in its pursuit of a nuclear waste dump and the impact it is having on South Bruce. If it did and cared about the negative impact it is having, it would surely leave South Bruce. Bravo NWMO, you should write a “how to” guide on how to groom small rural and northern communities into accepting your waste… or any kind of waste for that matter. We apologize, but this video has failed to load. Try refreshing ...